Results from a late-stage clinical trial are expected in December of this year and, if positive, could reignite Novo shares.

This placement comes ahead of the expected release ... combines two key components: semaglutide (already marketed as Wegovy for weight management) and cagrilintide, an amylin analogue, aimed at ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

participants gained most of their lost weight back after stopping semaglutide for a year. These people regained an average of ...

The previous phase III OASIS 1 study showed that 50 mg of oral semaglutide once a day resulted in an average 15.1% loss of ...

Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.